Christopher Schaber
Chief Executive Officer bei SOLIGENIX, INC.
Vermögen: 3 606 $ am 31.03.2024
Profil
Christopher J.
Schaber was the founder of Acute Therapeutics, Inc. (founded in 1996) where he held the title of VP-Regulatory Compliance & Drug Development from 1996 to 1998.
He is currently the Chairman, President & Chief Executive Officer at Soligenix, Inc. (since 2006), Director at BioNJ, Inc. (since 2009), Director at Alliance for Biosecurity (since 2014), Member-Corporate Councils at The National Organization for Rare Disorders, Inc. (since 2009), and Member-Corporate Council at American Society for Blood & Marrow Transplantation (since 2009).
In his former positions, he was a Director at BioSecurity Technologies, Inc., Worldwide Director-Regulatory Affairs & Operations at Ohmeda PPD, Inc. (1994-1996), Chief Operating Officer & Executive Vice President at Windtree Therapeutics, Inc. (1998-2006), and Chief Operating Officer & Executive Vice President at Discovery Laboratories, Inc. (1998-2006).
He obtained his undergraduate degree from McDaniel College, doctorate degree from Union Institute & University, and graduate degree from Temple University School of Pharmacy.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SOLIGENIX, INC.
0,06% | 08.03.2024 | 6 010 ( 0,06% ) | 3 606 $ | 31.03.2024 |
Aktive Positionen von Christopher Schaber
| Unternehmen | Position | Beginn |
|---|---|---|
| SOLIGENIX, INC. | Chief Executive Officer | 01.08.2006 |
The National Organization for Rare Disorders, Inc.
 The National Organization for Rare Disorders, Inc. Services to the Health IndustryHealth Services The National Organization for Rare Disorders, Inc. operates as a non-profit federation of voluntary health organizations to help individuals with diseases and disorders. Its services are focused on the identification, treatment, and cure of disorders through programs of education, advocacy, research, and service. The company was founded in 1983 and is headquartered in Danbury, CT. | Corporate Officer/Principal | 17.08.2010 |
| American Society for Blood & Marrow Transplantation | Corporate Officer/Principal | 17.08.2010 |
| Alliance for Biosecurity | Director/Board Member | 01.10.2014 |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Director/Board Member | - |
Ehemalige bekannte Positionen von Christopher Schaber
| Unternehmen | Position | Ende |
|---|---|---|
| WINDTREE THERAPEUTICS, INC. | Chief Operating Officer | 01.01.2006 |
| Discovery Laboratories, Inc. | Chief Operating Officer | 01.01.2006 |
| Acute Therapeutics, Inc. | Founder | 01.01.1998 |
| Ohmeda PPD, Inc. | General Counsel | 01.01.1996 |
| ░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Ausbildung von Christopher Schaber
| McDaniel College | Undergraduate Degree |
| Union Institute & University | Doctorate Degree |
| Temple University School of Pharmacy | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SOLIGENIX, INC. | Health Technology |
| WINDTREE THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 8 |
|---|---|
BioSecurity Technologies, Inc.
 BioSecurity Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services BioSecurity Technologies, Inc. is engaged in acquiring intellectual properties for the purpose of developing commercial potential through licensure and sale. The firm specializes in the areas of homeland security, national defense, and technology applications. The company is headquartered in Richmond, VA. | Commercial Services |
| Acute Therapeutics, Inc. | |
The National Organization for Rare Disorders, Inc.
The National Organization for Rare Disorders, Inc. Services to the Health IndustryHealth Services The National Organization for Rare Disorders, Inc. operates as a non-profit federation of voluntary health organizations to help individuals with diseases and disorders. Its services are focused on the identification, treatment, and cure of disorders through programs of education, advocacy, research, and service. The company was founded in 1983 and is headquartered in Danbury, CT. | Health Services |
| American Society for Blood & Marrow Transplantation | |
| Ohmeda PPD, Inc. | |
BioNJ, Inc.
BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Commercial Services |
| Alliance for Biosecurity | |
| Discovery Laboratories, Inc. |
